Literature DB >> 12125743

Intracellular deposition, microtubule destabilization, and transport failure: an "early" pathogenic cascade leading to synaptic decline.

Jennifer Bendiske1, Ebru Caba, Queenie B Brown, Ben A Bahr.   

Abstract

Protein deposition is a common event in age-related neurological diseases that are characterized by neuronal dysfunction and eventual cell death. Here, cultured hippocampal slices were infused with the lysosomal disrupter chloroquine to examine the link between abnormal protein processing/deposition and early synaptopathogenesis. Tau species of 55 to 69 kDa increased over several days of treatment with chloroquine, while the protein and message levels of synaptic markers were selectively reduced. Neurons of subfields CA1, CA3, and dentate gyrus accumulated protein deposits recognized by antibodies against paired helical filaments and ubiquitin, and this was accompanied by tubulin fragmentation and deacetylation. The deposition filled the basal pole of pyramidal neurons, encompassing the area of the axon hillock and initial dendritic branching but without causing overt neuronal atrophy. Neurons containing the polar aggregates exhibited severely impaired transport along basal dendrites. Transport capability was also lost along apical dendrites, the opposite direction of deposited material in the basal pole; thus, perpetuating the problem beyond physical blockage must be the associated loss of microtubule integrity. These data indicate that transport failure forms a link between tau deposition and synaptic decline, thus shedding light on how protein aggregation events disrupt synaptic and cognitive functions before the ensuing cellular destruction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12125743     DOI: 10.1093/jnen/61.7.640

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  27 in total

1.  Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases.

Authors:  Ben A Bahr; Meagan L Wisniewski; David Butler
Journal:  Rejuvenation Res       Date:  2012-04       Impact factor: 4.663

Review 2.  Neuroproteomics as a promising tool in Parkinson's disease research.

Authors:  Ilse S Pienaar; William M U Daniels; Jürgen Götz
Journal:  J Neural Transm (Vienna)       Date:  2008-06-04       Impact factor: 3.575

Review 3.  Involvement of organelles and inter-organellar signaling in the pathogenesis of HIV-1 associated neurocognitive disorder and Alzheimer's disease.

Authors:  Nabab Khan; Norman J Haughey; Avindra Nath; Jonathan D Geiger
Journal:  Brain Res       Date:  2019-08-16       Impact factor: 3.252

Review 4.  Novel therapeutics for Alzheimer's disease: an update.

Authors:  David J Bonda; Hyun-Pil Lee; Hyoung-gon Lee; Avi L Friedlich; George Perry; Xiongwei Zhu; Mark A Smith
Journal:  Curr Opin Drug Discov Devel       Date:  2010-03

5.  The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells.

Authors:  Cesar Augusto Dias de Paula; Fernando Enrique Santiago; Adriele Silva Alves de Oliveira; Fernando Augusto Oliveira; Maria Camila Almeida; Daniel Carneiro Carrettiero
Journal:  Cell Mol Neurobiol       Date:  2015-07-25       Impact factor: 5.046

6.  Potential Alzheimer's Disease Therapeutics Among Weak Cysteine Protease Inhibitors Exhibit Mechanistic Differences Regarding Extent of Cathepsin B Up-Regulation and Ability to Block Calpain.

Authors:  Heather Romine; Katherine M Rentschler; Kaitlan Smith; Ayanna Edwards; Camille Colvin; Karen Farizatto; Morgan C Pait; David Butler; Ben A Bahr
Journal:  Eur Sci J       Date:  2017-10

7.  Amyloid beta accumulation in HIV-1 infected brain: the role of altered cholesterol homeostasis.

Authors:  Xuesong Chen; Liang Hui; Jonathan D Geiger
Journal:  Clin Res HIV AIDS       Date:  2014-08-31

8.  Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo Neurotoxic Effects of Paraoxon.

Authors:  Karen L G Farizatto; Sara A McEwan; Vinogran Naidoo; Spyros P Nikas; Vidyanand G Shukla; Michael F Almeida; Aaron Byrd; Heather Romine; David A Karanian; Alexandros Makriyannis; Ben A Bahr
Journal:  J Mol Neurosci       Date:  2017-08-12       Impact factor: 3.444

9.  Gephyrin alterations due to protein accumulation stress are reduced by the lysosomal modulator Z-Phe-Ala-diazomethylketone.

Authors:  Sophia Ryzhikov; Ben A Bahr
Journal:  J Mol Neurosci       Date:  2007-09-18       Impact factor: 3.444

10.  HDAC6 regulates mitochondrial transport in hippocampal neurons.

Authors:  Sigeng Chen; Geoffrey C Owens; Helen Makarenkova; David B Edelman
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.